多元化医疗信托2026年季度报告

FORM10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐TRANSITION REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934Commission File Number 1-15319 DIVERSIFIED HEALTHCARE TRUST (Exact Name of Registrant as Specified in Its Charter) 04-3445278(I.R.S. Employer Identification No.) (State or Other Jurisdiction of Incorporation or Organization) Indicate by check mark whether the registrant:(1)has filed all reports required to be filed by Section13 or 15(d)of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filingrequirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or anemerging growth company.See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growthcompany” in Rule12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act).Yes☐No☒ Number of registrant's common shares outstanding as of April30, 2026:242,106,926 PagePARTIFinancial Information1 Item 1.Financial Statements (unaudited)1Condensed Consolidated Balance Sheets — March 31, 2026and December31, 20251Condensed Consolidated Statements of Comprehensive Income (Loss) — Three Months Ended March 31, 2026 and20252Condensed Consolidated Statements of Shareholders' Equity — Three Months Ended March 31, 2026 and 20253Condensed Consolidated Statements of Cash Flows — Three Months Ended March 31, 2026 and 20254Notes to Condensed Consolidated Financial Statements6Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations20Item 3.Quantitative and Qualitative Disclosures About Market Risk34Item 4.Controls and Procedures35Warning Concerning Forward-Looking Statements36Statement Concerning Limited Liability38PARTIIOther Information39Item1A.Risk Factors39Item 2.Unregistered Sales of Equity Securities and Use of Proceeds39Item 6.Exhibits39Signatures41 References in this Quarterly Report on Form10-Q to the Company, we, us or our include Diversified Healthcare Trust and its consolidatedsubsidiaries unless otherwise expressly stated or the context indicates otherwise. DIVERSIFIED HEALTHCARE TRUSTCONDENSED CONSOLIDATED BALANCE SHEETS DIVERSIFIED HEALTHCARE TRUSTCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED) Supplemental disclosure of cash and cash equivalents and restricted cash: The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within our condensedconsolidated balance sheets to the amount shown in our condensed consolidated statements of cash flows: The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. Table of Contents DIVERSIFIED HEALTHCARE TRUSTNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)(dollar amounts in thousands, except per share data or as otherwise stated) Note 1.Basis of Presentation The accompanying condensed consolidated financial statements of Diversified Healthcare Trust and its subsidiaries, or DHC, we, us,or our, are unaudited.Certain information and disclosures required by U.S. generally accepted accounting principles, or GAAP, forcomplete financial statements have been condensed or omitted.We believe the disclosures made are adequate to make the information In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement ofresults for the interim period have been included. All intercompany transactions and balances with or among our consolidated subsidiaries The preparation of these financial statements in conformity with GAAP requires us to make estimates and assumptions that affectreported amounts. Actual results could differ from those estimates.Significant estimates in our condensed consolidated financialstatements include purchase price allocations, useful lives of fixed assets and impairments of real estate and intangible assets. We have been, are currently and expect in the future to be involved in claims, lawsuits and regulatory and other governmental audits,investigations and pr